Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Cancelled Pre Market
Current status date:
2024-06-13
Original market date: See footnote 1
Product name:
INPROSUB
DIN:
02515504
Product Monograph/Veterinary Labelling:
Date:
2021-06-21
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
IBSA INSTITUT BIOCHIMIQUE SA
Via Pian Scairolo 49
Pazzallo
--
Switzerland
6912
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Subcutaneous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
68:32.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
G03DA04 PROGESTERONE
Active ingredient group (AIG) number:See footnote5
0106327010
| Active ingredient(s) | Strength |
|---|---|
| PROGESTERONE | 25 MG / 1.112 ML |